- Home
- GCTK vs ACON Comparison
GCTK vs ACON Comparison
Compare GCTK & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- ACON
- Stock Information
- Founded
- GCTK 2001
- ACON 2008
- Country
- GCTK United States
- ACON United States
- Employees
- GCTK N/A
- ACON N/A
- Industry
- GCTK Medical/Dental Instruments
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- GCTK Health Care
- ACON Technology
- Exchange
- GCTK Nasdaq
- ACON Nasdaq
- Market Cap
- GCTK 4.1M
- ACON 4.2M
- IPO Year
- GCTK N/A
- ACON 2022
- Fundamental
- Price
- GCTK $6.59
- ACON $7.28
- Analyst Decision
- GCTK
- ACON Buy
- Analyst Count
- GCTK 0
- ACON 2
- Target Price
- GCTK N/A
- ACON $481.00
- AVG Volume (30 Days)
- GCTK 1.6M
- ACON 15.5K
- Earning Date
- GCTK 08-12-2025
- ACON 08-13-2025
- Dividend Yield
- GCTK N/A
- ACON N/A
- EPS Growth
- GCTK N/A
- ACON N/A
- EPS
- GCTK N/A
- ACON N/A
- Revenue
- GCTK N/A
- ACON $54,601.00
- Revenue This Year
- GCTK N/A
- ACON $212.31
- Revenue Next Year
- GCTK N/A
- ACON $92.86
- P/E Ratio
- GCTK N/A
- ACON N/A
- Revenue Growth
- GCTK N/A
- ACON N/A
- 52 Week Low
- GCTK $5.16
- ACON $6.20
- 52 Week High
- GCTK $3,756.00
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- GCTK 35.94
- ACON 42.96
- Support Level
- GCTK $5.94
- ACON $6.79
- Resistance Level
- GCTK $15.90
- ACON $7.29
- Average True Range (ATR)
- GCTK 1.57
- ACON 0.37
- MACD
- GCTK -0.01
- ACON 0.31
- Stochastic Oscillator
- GCTK 0.56
- ACON 45.79
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.